Young Ho Lee1, Jong Dae Ji, Gwan Gyu Song. 1. Division of Rheumatology, Department of Internal Medicine, Korea University Medical Center, Korea University, College of Medicine, Seoul, Korea. lyhcgh@korea.ac.kr
Abstract
OBJECTIVE: .To investigate whether the Fcgamma receptor (FCGR) polymorphism confers susceptibility to rheumatoid arthritis (RA). METHODS: We conducted metaanalyses on the associations between FCGR polymorphisms and RA susceptibility as determined using (1) allele contrast, (2) recessive models, (3) dominant models, and (4) contrast of homozygotes, using fixed or random effects models. RESULTS: A total of 10 separate comparisons were considered, which comprised 6 European and 4 Asian population samples. Metaanalysis of FCGR3A polymorphism revealed a significant association between the VV genotype and the risk of developing RA relative to the VF+FF genotype (OR 1.256, 95% CI 1.045-1.510, p = 0.015), with no evidence of between-study heterogeneity (p = 0.167). In subjects of European descent, a stronger association was observed between the VV genotype and RA than for the FF genotype (OR 1.374, 95% CI 1.101-1.714, p = 0.005). In Asians, no such association was found. Metaanalysis of the VV vs FF genotype revealed a significantly increased OR in Europeans (OR 1.399, 95% CI 1.107-1.769, p = 0.005), but not in Asians. No association was found between RA and the FCGR2A and FCGR3B polymorphisms in all subjects and in European and Asian populations, except for the NA22 vs NA11 of FCGR3B in Europeans. CONCLUSION: No relation was found between the FCGR2A polymorphism and susceptibility to RA in Europeans or Asians. The FCGR3A polymorphism was found to be associated with RA in Europeans but not in Asians. The FCGR3B polymorphism was associated with RA susceptibility in Europeans.
OBJECTIVE: .To investigate whether the Fcgamma receptor (FCGR) polymorphism confers susceptibility to rheumatoid arthritis (RA). METHODS: We conducted metaanalyses on the associations between FCGR polymorphisms and RA susceptibility as determined using (1) allele contrast, (2) recessive models, (3) dominant models, and (4) contrast of homozygotes, using fixed or random effects models. RESULTS: A total of 10 separate comparisons were considered, which comprised 6 European and 4 Asian population samples. Metaanalysis of FCGR3A polymorphism revealed a significant association between the VV genotype and the risk of developing RA relative to the VF+FF genotype (OR 1.256, 95% CI 1.045-1.510, p = 0.015), with no evidence of between-study heterogeneity (p = 0.167). In subjects of European descent, a stronger association was observed between the VV genotype and RA than for the FF genotype (OR 1.374, 95% CI 1.101-1.714, p = 0.005). In Asians, no such association was found. Metaanalysis of the VV vs FF genotype revealed a significantly increased OR in Europeans (OR 1.399, 95% CI 1.107-1.769, p = 0.005), but not in Asians. No association was found between RA and the FCGR2A and FCGR3B polymorphisms in all subjects and in European and Asian populations, except for the NA22 vs NA11 of FCGR3B in Europeans. CONCLUSION: No relation was found between the FCGR2A polymorphism and susceptibility to RA in Europeans or Asians. The FCGR3A polymorphism was found to be associated with RA in Europeans but not in Asians. The FCGR3B polymorphism was associated with RA susceptibility in Europeans.
Authors: Chaoling Dong; Travis S Ptacek; David T Redden; Kui Zhang; Elizabeth E Brown; Jeffrey C Edberg; Gerald McGwin; Graciela S Alarcón; Rosalind Ramsey-Goldman; John D Reveille; Luis M Vilá; Michelle Petri; Aijian Qin; Jianming Wu; Robert P Kimberly Journal: Arthritis Rheumatol Date: 2014-05 Impact factor: 10.995
Authors: Rute B Marques; Mohamed M Thabet; Stefan J White; Jeanine J Houwing-Duistermaat; Aleida M Bakker; Gert-Jan Hendriks; Alexandra Zhernakova; Tom W Huizinga; Annette H van der Helm-van Mil; Rene E Toes Journal: PLoS One Date: 2010-10-05 Impact factor: 3.240
Authors: Cushla McKinney; Manuela Fanciulli; Marilyn E Merriman; Amanda Phipps-Green; Behrooz Z Alizadeh; Bobby P C Koeleman; Nicola Dalbeth; Peter J Gow; Andrew A Harrison; John Highton; Peter B Jones; Lisa K Stamp; Sophia Steer; Pilar Barrera; Marieke J H Coenen; Barbara Franke; Piet L C M van Riel; Tim J Vyse; Tim J Aitman; Timothy R D J Radstake; Tony R Merriman Journal: Ann Rheum Dis Date: 2010-05-14 Impact factor: 19.103
Authors: Manuela Moraru; Adriana Perez-Portilla; Karima Al-Akioui Sanz; Alfonso Blazquez-Moreno; Antonio Arnaiz-Villena; Hugh T Reyburn; Carlos Vilches Journal: Front Immunol Date: 2021-05-24 Impact factor: 7.561
Authors: Alf Kastbom; Lars Cöster; Lisbeth Arlestig; Aikaterini Chatzidionysiou; Ronald F van Vollenhoven; Leonid Padyukov; Solbritt Rantapää-Dahlqvist; Saedis Saevarsdottir Journal: BMJ Open Date: 2012-09-22 Impact factor: 2.692